Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce the signing of a licence agreement to expand PromarkerD s reach in Central and South America.
Proteomics International Laboratories Ltd is pleased to announce the signing of a licence agreement to expand PromarkerD s reach in Central and South America. The deal with long-standing partner.
Proteomics International Laboratories Ltd is pleased to release a copy of the Chairman s Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to release a copy of the Chairman s Address provided by Mr Neville Gardiner and the Investor Presentation provided by Dr Richard Lipscombe to shareholders.
Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that the US Centers for Medicare & Medicaid Services has published its final determination of the national reimbursement price in the United States for the PromarkerD predictive test for diabetic kidney disease.